Today more than ever, effective pharmaceutical risk management is critical to successful drug development and commercialization. In recent years, the FDA and EMEA have released risk management guidance documents that underscore the need for risk management programs throughout the life cycle of a drug. In this evolving regulatory environment, risk management has become a key initiative within the industry. We are at the forefront of these changes as our experts work with regulatory agencies, academic institutions, professional societies and pharmaceutical companies to shape, implement and refine risk management practices.
The goal of a risk management plan (RMP) is to reduce risks to patients while preserving access to treatment. Potential drug safety risks that can be better controlled with an effective RMP include: drug-drug interactions, usage problems (e.g., dose, storage, or delivery), medication errors, abuse and diversion and use in high-risk patients or circumstances. Our experts provide comprehensive consulting services and conduct studies to help you meet your risk management objectives at each phase of your product's lifecycle:
